222 related articles for article (PubMed ID: 21914171)
1. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients.
Appaiah HN; Goswami CP; Mina LA; Badve S; Sledge GW; Liu Y; Nakshatri H
Breast Cancer Res; 2011 Sep; 13(5):R86. PubMed ID: 21914171
[TBL] [Abstract][Full Text] [Related]
2. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
3. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
McDermott AM; Kerin MJ; Miller N
PLoS One; 2013; 8(12):e83718. PubMed ID: 24391813
[TBL] [Abstract][Full Text] [Related]
5. Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers.
Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Faridová A; Turyna R; Slanař O; Hořínek A; Kohoutová M
Mol Biol Rep; 2022 Mar; 49(3):1955-1971. PubMed ID: 34993725
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
[TBL] [Abstract][Full Text] [Related]
7. Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients.
Alunni-Fabbroni M; Majunke L; Trapp EK; Tzschaschel M; Mahner S; Fasching PA; Fehm T; Schneeweiss A; Beck T; Lorenz R; Friedl TWP; Janni W; Rack B;
BMC Cancer; 2018 Feb; 18(1):141. PubMed ID: 29409452
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CDK inhibitor p27 by microRNA 222 in breast cancer patients.
Said MN; Muawia S; Helal A; Fawzy A; Allam RM; Shafik NF
Exp Mol Pathol; 2021 Dec; 123():104718. PubMed ID: 34752733
[TBL] [Abstract][Full Text] [Related]
9. Selection and validation of endogenous controls for microRNA expression studies in endometrioid endometrial cancer tissues.
Torres A; Torres K; Wdowiak P; Paszkowski T; Maciejewski R
Gynecol Oncol; 2013 Sep; 130(3):588-94. PubMed ID: 23811003
[TBL] [Abstract][Full Text] [Related]
10. Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder.
Liu X; Zhang L; Cheng K; Wang X; Ren G; Xie P
J Affect Disord; 2014 Jul; 163():133-9. PubMed ID: 24479999
[TBL] [Abstract][Full Text] [Related]
11. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB
BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
[TBL] [Abstract][Full Text] [Related]
13. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
14. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis.
Benz F; Roderburg C; Vargas Cardenas D; Vucur M; Gautheron J; Koch A; Zimmermann H; Janssen J; Nieuwenhuijsen L; Luedde M; Frey N; Tacke F; Trautwein C; Luedde T
Exp Mol Med; 2013 Sep; 45(9):e42. PubMed ID: 24052167
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of serum miR-21 in the pathogenesis of familial and triple negative breast cancer.
Yang L; Feng Y; Qi P; Xu S; Zhou Y
J Biol Regul Homeost Agents; 2016; 30(4):1041-1045. PubMed ID: 28078851
[TBL] [Abstract][Full Text] [Related]
16. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
[TBL] [Abstract][Full Text] [Related]
17. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
18. Potential value of circulatory microRNA122 gene expression as a prognostic and metastatic prediction marker for breast cancer.
Saleh AA; Soliman SE; Habib MSE; Gohar SF; Abo-Zeid GS
Mol Biol Rep; 2019 Jun; 46(3):2809-2818. PubMed ID: 30835039
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
20. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients.
Song J; Bai Z; Han W; Zhang J; Meng H; Bi J; Ma X; Han S; Zhang Z
Dig Dis Sci; 2012 Apr; 57(4):897-904. PubMed ID: 22198701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
